HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corneal Perforation

A puncture or hole through the CORNEAL STROMA resulting from various diseases or trauma.
Also Known As:
Corneal Perforations; Perforation, Corneal; Perforations, Corneal
Networked: 698 relevant articles (47 outcomes, 26 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Ulcer
2. Keratitis
3. Keratoconus
4. Burns
5. Glaucoma

Experts

1. Sharma, Namrata: 12 articles (11/2022 - 08/2002)
2. Lietman, Thomas M: 10 articles (07/2021 - 06/2010)
3. Shi, Weiyun: 10 articles (01/2020 - 02/2007)
4. Hazlett, Linda D: 9 articles (08/2011 - 01/2002)
5. Sharma, Ashok: 7 articles (01/2022 - 02/2003)
6. Prajna, N Venkatesh: 7 articles (07/2021 - 04/2013)
7. Rajaraman, Revathi: 7 articles (07/2021 - 04/2013)
8. Rose-Nussbaumer, Jennifer: 7 articles (07/2021 - 12/2016)
9. Titiyal, Jeewan S: 7 articles (03/2021 - 08/2002)
10. Krishnan, Tiruvengada: 7 articles (01/2020 - 06/2010)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Corneal Perforation:
1. CyanoacrylatesIBA
2. Fibrin Tissue Adhesive (Fibrin Sealant)IBA
3. Tissue Adhesives (Tissue Adhesive)IBA
4. SteroidsIBA
5. CytokinesIBA
6. CollagenIBA
7. Voriconazole (Vfend)FDA LinkGeneric
12/01/2016 - "Overall, no difference in the rate of corneal perforation or the need for TPK was determined for oral voriconazole vs placebo (hazard ratio, 0.82; 95% CI, 0.57-1.18; P = .29). "
11/01/2007 - "Fungal cultures of corneal scrapings revealed growth of Scedosporium apiospermum, a strain for which the main antifungals showed high minimal inhibitory concentrations (MICs), whereas the MIC of voriconazole was 0.125 microg/mL. Despite some improvement with topical 1% voriconazole and oral voriconazole (200 mg/day) treatment, a therapeutic penetrating keratoplasty was performed because of the high risk of corneal perforation. "
06/01/2010 - "Corneal perforations in the voriconazole group (10 of 60 patients) were not significantly different than in the natamycin-treated group (9 of 60 patients) (P >.99). "
04/09/2015 - "On average, people randomised to natamycin had better spectacle-corrected visual acuity at two to three months compared to people randomised to voriconazole but the estimate was uncertain and the 95% confidence intervals included 0 (no difference) (mean difference -0.12 logMAR, 95% CI -0.31 to 0.06, 434 participants; 3 studies, low quality evidence) and a decreased risk of corneal perforation or therapeutic penetrating keratoplasty, or both (RR 0.61; 95% CI 0.40 to 0.94, 434 participants, high quality evidence). "
05/01/2012 - "Despite aggressive antifungal therapy with voriconazole and amphotericin B, she required penetrating keratoplasty for impending corneal perforation. "
8. FibrinIBA
9. spantideIBA
10. Anti-Bacterial Agents (Antibiotics)IBA

Therapies and Procedures

1. Transplantation
2. Penetrating Keratoplasty
3. Corneal Transplantation (Keratoplasty)
4. Emergency Treatment
5. Contact Lenses